How to Evaluate a Peptide Clinic
Red flags and quality signals when assessing clinics offering peptide treatments.
Last updated: 27 March 2026
Practitioner credentials
Check that practitioners are registered with the Australian Health Practitioner Regulation Agency (AHPRA) and hold appropriate qualifications. Verify their specialty and experience. Clinics should publish practitioner credentials publicly.
Practitioners must be legally entitled to prescribe the peptides they are offering.
Pre-treatment assessment
Good clinics conduct thorough health assessments: medical history, physical examination, baseline testing (bloods, etc.). They do not prescribe without assessment. They discuss risks and benefits.
Red flag: clinics that prescribe on a first visit without proper assessment.
Monitoring and follow-up
Responsible clinics monitor patients during treatment: regular check-ins, repeat testing at intervals, adverse-event monitoring, and adjustment of treatment as needed.
Red flag: clinics that prescribe and then do not follow up.
Transparency and disclosure
Good clinics disclose: what peptides are being used, why, what evidence supports the use, what the costs are, what the risks are, and what to expect.
Red flags: vague about peptide identity, claims of 'proprietary blends', refusal to name the peptides used.
Critical red flags
Practitioners not registered with AHPRA. Therapeutic claims without supporting evidence. Refusal to provide written information. High-pressure sales tactics. Expensive packages with no clear medical indication.